GLP-1: physiological effects and potential therapeutic applications

Medicin og biovidenskab

• Glucagon-Like Peptide 1 100%
• Incretins 88%
• Therapeutic Uses 70%
• Dipeptidyl-Peptidase IV Inhibitors 45%
• Hypoglycemic Agents 32%
• Weight Loss 28%
• Type 2 Diabetes Mellitus 25%
• Glucagon-Like Peptide-1 Receptor 22%
• Gastrointestinal Motility 20%
• Glucagon 17%
• Insulin Secretion 16%
• Type 1 Diabetes Mellitus 15%
• Diabetes Mellitus 13%
• Eating 12%
• Hormones 12%
• Cell Proliferation 11%
• Clinical Trials 11%
• Weights and Measures 10%
• Apoptosis 10%
• Animals 8%
• Therapeutics 8%